Researchers at Brown University are working on a sensor that can check blood sugar levels by measuring glucose concentrations in saliva, rather than in blood.
According to a statement, the technique takes advantage of a convergence of nanotechnology and surface plasmonics, which explores the interaction of electrons and photons.
The engineers at Brown etched thousands of plasmonic interferometers onto a fingernail-size biochip and measured the concentration of glucose molecules in water on the chip.
Their results showed that the biochip could detect glucose levels similar to the levels found in human saliva. Glucose in human saliva is typically about 100 times less concentrated than in the blood.
‘This is proof of concept that plasmonic interferometers can be used to detect molecules in low concentrations, using a footprint that is 10 times smaller than a human hair,’ said Domenico Pacifici, assistant professor of engineering and lead author of a paper on the research published in Nano Letters.
The technique can be used to detect other chemicals or substances, from anthrax to biological compounds, Pacifici said, and detect them at once, in parallel, using the same chip.
To create the sensor, the researchers carved a slit about 100nm wide and etched two 200nm-wide grooves on either side of the slit.
The slit captures incoming photons and confines them. The grooves, meanwhile, scatter the incoming photons, which interact with the free electrons on the sensor’s metal surface.
Those free electron-photon interactions create a surface plasmon polariton, a special wave with a wavelength that is narrower than a photon in free space.
These surface plasmon waves move along the sensor’s surface until they encounter the photons in the slit. This ‘interference’ between the two waves determines maxima and minima in the light intensity transmitted through the slit.
The presence of an analyte on the sensor surface generates a change in the relative phase difference between the two surface plasmon waves, which in turn causes a change in light intensity — measured by the researchers in real time.
‘The slit is acting as a mixer for the three beams — the incident light and the surface plasmon waves,’ Pacifici said.
The engineers realised they could vary the phase shift for an interferometer by changing the distance between the grooves and the slit, meaning they could tune the interference generated by the waves. The researchers could tune the thousands of interferometers to establish baselines, which could then be used to accurately measure concentrations of glucose in water as low as 0.36mg per decilitre.
‘It could be possible to use these biochips to carry out the screening of multiple biomarkers for individual patients, all at once and in parallel, with unprecedented sensitivity,’ Pacifici said.
The engineers next plan to build sensors tailored for glucose and for other substances to further test the devices.